Exelixis
EXEL
#1807
Rank
A$16.63 B
Marketcap
A$62.05
Share price
2.86%
Change (1 day)
13.65%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company